SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

VolitionRx Signs Non-Binding LOI With Missionpharma for NETosis Technology

VolitionRx says it executed a non-binding letter of intent with Missionpharma to explore development and worldwide launch of its lateral flow technology for NETosis.

Related stories